Elanco Animal Health (ELAN) Total Debt (2018 - 2026)
Elanco Animal Health (ELAN) posted Total Debt of $3.8 billion for Q1 2026, down 0.7% sequentially from $3.8 billion in Q4 2025, and down 13.33% YoY from $4.4 billion in Q1 2025.
Elanco Animal Health (ELAN) Total Debt (2018 - 2026) Analysis & Trends
Elanco Animal Health has reported Total Debt for 9 years, with the latest figure at $3.8 billion in Q1 2026.
- Quarterly Total Debt fell 13.33% year-over-year to $3.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 billion (down 13.33% YoY) and the FY2025 annual result came in at $3.8 billion, down 11.22% from the prior year.
- Total Debt slipped to $3.8 billion in Q1 2026 per ELAN's latest filing, from $3.8 billion in the prior quarter.
- Over five years, Total Debt peaked at $6.3 billion in Q3 2022 and troughed at $3.8 billion in Q1 2026.
- A 5-year average of $5.1 billion and a median of $5.8 billion in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2023 and 2024: Total Debt gained 0.63% in 2023, then slipped 25.68% in 2024.
- Over 5 years, Total Debt stood at $5.8 billion in 2022, then decreased by 0.41% to $5.8 billion in 2023, then retreated by 25.65% to $4.3 billion in 2024, then decreased by 11.22% to $3.8 billion in 2025, then slipped by 0.7% to $3.8 billion in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $3.8 billion, $3.8 billion, and $4.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 760.00 Mn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.92 Bn |
| Mar 31, 2026 | 3.81 Bn |
| Dec 31, 2025 | 3.84 Bn |
| Sep 30, 2025 | 4.02 Bn |
| Jun 30, 2025 | 4.21 Bn |
| Mar 31, 2025 | 4.40 Bn |
| Dec 31, 2024 | 4.32 Bn |
| Sep 30, 2024 | 4.40 Bn |
| Jun 30, 2024 | 4.53 Bn |
| Mar 31, 2024 | 5.77 Bn |
| Dec 31, 2023 | 5.81 Bn |
| Sep 30, 2023 | 5.91 Bn |
| Jun 30, 2023 | 6.10 Bn |
| Mar 31, 2023 | 6.02 Bn |
| Dec 31, 2022 | 5.84 Bn |
| Sep 30, 2022 | 6.30 Bn |
| Jun 30, 2022 | 6.06 Bn |
| Mar 31, 2022 | 6.20 Bn |
| Dec 31, 2021 | 6.61 Bn |
| Sep 30, 2021 | 6.40 Bn |